Total Payments
$48,793
2024 Payments
$926.74
Companies
39
Transactions
265
Medicare Patients
20,570
Medicare Billing
$2.9M
Payment Breakdown by Category
Royalty/License$40,177 (82.3%)
Food & Beverage$8,606 (17.6%)
Education$10.28 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $40,177 | 2 | 82.3% |
| Food and Beverage | $8,606 | 262 | 17.6% |
| Education | $10.28 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $40,253 | 3 | $0 (2019) |
| Abbott Laboratories | $2,856 | 42 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $599.74 | 21 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $594.68 | 21 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $421.36 | 18 | $0 (2024) |
| Boston Scientific Corporation | $330.45 | 9 | $0 (2024) |
| Amarin Pharma Inc. | $308.69 | 14 | $0 (2021) |
| PFIZER INC. | $296.73 | 14 | $0 (2024) |
| Amgen Inc. | $288.34 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $275.89 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $926.74 | 27 | Abbott Laboratories ($312.70) |
| 2023 | $1,052 | 35 | Abbott Laboratories ($384.33) |
| 2022 | $792.35 | 36 | Impulse Dynamics (USA) Inc. ($158.99) |
| 2021 | $794.57 | 47 | Amarin Pharma Inc. ($137.21) |
| 2020 | $1,042 | 34 | Abbott Laboratories ($276.08) |
| 2019 | $26,821 | 21 | Medtronic Vascular, Inc. ($25,857) |
| 2018 | $15,687 | 29 | Medtronic Vascular, Inc. ($14,397) |
| 2017 | $1,677 | 36 | Abbott Laboratories ($937.57) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $35.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Heart Failure | ||||||
| 08/28/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.92 | General |
| 08/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.70 | General |
| Category: Cardiovascular | ||||||
| 06/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.61 | General |
| Category: Cardiovascular | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiology | ||||||
| 05/20/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $171.48 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/15/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $26.14 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 03/07/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/26/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $76.31 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/20/2024 | Abbott Laboratories | ENSITE PRECISION (Device) | Food and Beverage | In-kind items and services | $128.79 | General |
| Category: Electrophysiology | ||||||
| 02/07/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $91.99 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 5,291 | 7,107 | $2.4M | $760,699 |
| 2022 | 35 | 4,897 | 6,524 | $2.2M | $714,095 |
| 2021 | 42 | 5,252 | 7,123 | $2.3M | $758,322 |
| 2020 | 39 | 5,130 | 6,819 | $2.1M | $648,350 |
Total Patients
20,570
Total Services
27,573
Medicare Billing
$2.9M
Procedure Codes
157
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 102 | 102 | $609,960 | $201,219 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 798 | 1,451 | $409,523 | $141,390 | 34.5% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 102 | 106 | $94,812 | $64,480 | 68.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 279 | 284 | $188,212 | $53,677 | 28.5% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 76 | 77 | $140,448 | $52,449 | 37.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 276 | 277 | $144,318 | $38,974 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 406 | 488 | $94,886 | $32,754 | 34.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 210 | 215 | $109,399 | $30,550 | 27.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 128 | 512 | $153,372 | $21,713 | 14.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 137 | 139 | $74,921 | $20,932 | 27.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 54 | 54 | $68,172 | $18,927 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $54,400 | $15,522 | 28.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 792 | 1,013 | $44,708 | $11,267 | 25.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 173 | 173 | $32,051 | $9,447 | 29.5% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 68 | 79 | $40,380 | $6,979 | 17.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 54 | 58 | $22,032 | $4,555 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 302 | 509 | $5,090 | $4,276 | 84.0% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 20 | 20 | $10,520 | $4,266 | 40.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 28 | $10,584 | $3,684 | 34.8% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 52 | 57 | $13,144 | $2,539 | 19.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 154 | 174 | $7,308 | $2,283 | 31.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 178 | 200 | $7,200 | $2,070 | 28.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 32 | $5,984 | $2,040 | 34.1% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 17 | 17 | $5,015 | $1,886 | 37.6% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 41 | 49 | $5,145 | $1,885 | 36.6% |
About Dr. Marcy Lim, M.D
Dr. Marcy Lim, M.D is a Cardiovascular Disease healthcare provider based in Humble, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578671392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcy Lim, M.D has received a total of $48,793 in payments from pharmaceutical and medical device companies, with $926.74 received in 2024. These payments were reported across 265 transactions from 39 companies. The most common payment nature is "Royalty or License" ($40,177).
As a Medicare-enrolled provider, Lim has provided services to 20,570 Medicare beneficiaries, totaling 27,573 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Humble, TX
- Active Since 08/29/2006
- Last Updated 01/29/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1578671392
Products in Payments
- VenaSeal (Device) $40,177
- XARELTO (Drug) $599.74
- Ensite Cardiac Mapping System (Device) $599.23
- ELIQUIS (Drug) $382.41
- Pacemakers (Device) $352.85
- VENOVO (Device) $349.58
- CRT-Ds (Device) $345.48
- Vascepa (Drug) $308.69
- LifeVest (Device) $273.94
- Barostim Neo System (Device) $259.97
- ENTRESTO (Drug) $258.70
- Repatha (Biological) $234.70
- WATCHMAN (Device) $205.25
- Connectivity and Remote care (Device) $199.70
- AVEIR (Device) $175.48
- Confirm Rx (Device) $173.37
- LEQVIO (Drug) $162.66
- Optimizer (Device) $158.99
- LEXISCAN (Drug) $152.88
- Livalo (Drug) $138.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Humble
Dr. Khaled Khalaf, M.d, M.D
Cardiovascular Disease — Payments: $153,573
Cardiovascular Disease $153,573
Mary Lim-Fung, Do, DO
Cardiovascular Disease — Payments: $83,877
Cardiovascular Disease $83,877
Dr. Bartosz Jozwik, M.d, M.D
Cardiovascular Disease — Payments: $56,911
Cardiovascular Disease $56,911
David Wong, M.d, M.D
Cardiovascular Disease — Payments: $41,289
Cardiovascular Disease $41,289
Aakash Shah, Md, MD
Cardiovascular Disease — Payments: $38,759
Cardiovascular Disease $38,759
Raymond Little, Md, MD
Cardiovascular Disease — Payments: $36,013
Cardiovascular Disease $36,013